Stegent Equity Advisors, Inc. Novo Nordisk A S Transaction History
Stegent Equity Advisors, Inc.
- $102 Million
- Q3 2025
A detailed history of Stegent Equity Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Stegent Equity Advisors, Inc. holds 4,975 shares of NVO stock, worth $263,127. This represents 0.27% of its overall portfolio holdings.
Number of Shares
4,975
Previous 5,243
5.11%
Holding current value
$263,127
Previous $361,000
23.55%
% of portfolio
0.27%
Previous 0.37%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,705Shares Held
311MCall Options Held
13.7MPut Options Held
19.7M-
Bank Of America Corp Charlotte, NC14.7MShares$779 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$756 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$665 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$615 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$582 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $119B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...